Alliancebernstein L.P. Voyager Therapeutics, Inc. Transaction History

Alliancebernstein L.P.

$287 Billion
Q3 2024

A detailed history of Alliancebernstein L.P. transactions in Voyager Therapeutics, Inc. stock. As of the latest transaction made, Alliancebernstein L.P. holds 36,750 shares of VYGR stock, worth $206,902. This represents 0.0% of its overall portfolio holdings.

Number of Shares

36,750

Previous 36,750 -0.0%

Holding current value

$206,902

Previous $290,000 26.21%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$7.42 - $10.54 $156,858 - $222,815	21,140 Added 135.43%	36,750 $290,000
Q1 2024 May 14, 2024	SELL	$7.15 - $10.84 $45,188 - $68,508	-6,320 Reduced 28.82%	15,610 $145,000
Q3 2023 Nov 14, 2023	BUY	$7.55 - $11.25 $20,309 - $30,262	2,690 Added 13.98%	21,930 $169,000
Q2 2023 Aug 15, 2023	BUY	$6.94 - $13.99 $133,525 - $269,167	19,240 New	19,240 $220,000
Q2 2021 Jul 30, 2021	SELL	$3.94 - $5.44 $126,080 - $174,080	-32,000 Closed	0 $0
Q1 2021 May 06, 2021	SELL	$4.61 - $9.04 $23,050 - $45,199	-5,000 Reduced 13.51%	32,000 $151,000
Q3 2020 Nov 12, 2020	SELL	$10.01 - $13.75 $14,014 - $19,250	-1,400 Reduced 3.65%	37,000 $395,000
Q2 2020 Aug 13, 2020	BUY	$8.05 - $14.21 $27,370 - $48,314	3,400 Added 9.71%	38,400 $485,000
Q1 2020 May 14, 2020	BUY	$6.8 - $14.66 $34,680 - $74,766	5,100 Added 17.06%	35,000 $320,000
Q3 2019 Nov 14, 2019	SELL	$16.31 - $28.29 $78,288 - $135,792	-4,800 Reduced 13.83%	29,900 $515,000
Q2 2019 Aug 14, 2019	BUY	$19.18 - $27.88 $26,852 - $39,032	1,400 Added 4.2%	34,700 $945,000
Q1 2019 May 14, 2019	BUY	$8.0 - $19.66 $31,200 - $76,674	3,900 Added 13.27%	33,300 $637,000
Q4 2018 Feb 13, 2019	BUY	$8.59 - $18.05 $26,629 - $55,955	3,100 Added 11.79%	29,400 $276,000
Q3 2018 Nov 08, 2018	BUY	$17.11 - $21.74 $42,775 - $54,349	2,500 Added 10.5%	26,300 $498,000
Q2 2018 Aug 13, 2018	BUY	$16.76 - $23.92 $134,080 - $191,360	8,000 Added 50.63%	23,800 $465,000
Q1 2018 May 14, 2018	BUY	$16.16 - $31.31 $50,096 - $97,061	3,100 Added 24.41%	15,800 $297,000
Q4 2017 Feb 13, 2018	BUY	$12.26 - $25.88 $26,972 - $56,936	2,200 Added 20.95%	12,700 $211,000
Q3 2017 Nov 13, 2017	BUY	$8.37 - $20.59 $87,884 - $216,195	10,500	10,500 $216,000

Others Institutions Holding VYGR

# of Institutions

130

Shares Held

34.7M

Call Options Held

39.7K

Put Options Held

34.6K

View Full List

About Voyager Therapeutics, Inc.

Ticker VYGR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,647,600
Market Cap $218M
Description
Voyager Therapeutics, Inc., a gene therapy company, focuses on the development of treatments and next-generation platform technologies. The company's lead clinical candidate is the VY-AADC, which is in open-label Phase 1 clinical trial for the treatment of Parkinson's disease. Its preclinical programs comprise VY-SOD102 for the treatment of amyo...

More about VYGR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.

Account

Alliancebernstein L.P. Voyager Therapeutics, Inc. Transaction History